Results 1 - 5 of 47 for: "PegIntron"
Refine your search:Drug Interactions  

Pegintron
PegIntron, peginterferon alfa-2b, Powder for Injection is a covalent conjugate of recombinant alfa-2b interferon with monomethoxy polyethylene glycol (PEG). The average molecular weight of the PEG portion of the molecule is 12,000 daltons. The average molecular weight of the PegIntron molecule is...
Professional Monographs (FDA) · More like this

peginterferon alfa-2b
...light. Do not allow the medicine to freeze. Mixed medicine may be stored in the refrigerator but you must use it within 24 hours after mixing. The PegIntron Redipen and single-use vials are for one use only. Do not reuse a vial or injection pen. What happens if I miss a dose? Use the medicine as soon...
Consumer Information (Cerner Multum) · More like this · Add to my drug list

Rebetol
...chronic hepatitis C infection. It is not known how Rebetol and interferon alfa-2b work together to fight hepatitis C infection (see the INTRON A or PegIntron Medication Guide). It is not known if treatment with Rebetol and interferon alfa-2b will cure hepatitis C virus infections or prevent cirrhosis,...
Professional Monographs (FDA) · More like this · Add to my drug list

Pegintron Plus Weight-Based Rebetol Resulted in Higher SVR Than Flat Dosing; Low Relapse Rates in Patients With Chronic Hepatitis C
...2008 /PRNewswire/ -- Schering-Plough Corporation today reported that the U.S. Food and Drug Administration (FDA) has approved label revisions for PEGINTRON(TM) (peginterferon alfa-2b) and REBETOL(R) (ribavirin, USP) combination therapy for chronic hepatitis C, recommending weight-based dosing of...
News & Articles (Drugs.com) · More like this

Schering-Plough Announces FDA Approval of PegIntron and Rebetol Combination Therapy for Treating Pediatric Hepatitis C
...-- Schering-Plough Corporation today announced that the U.S. Food and Drug Administration (FDA) has granted marketing approval to PegIntron (peginterferon alfa-2b) and Rebetol (ribavirin, USP) combination therapy for use in previously untreated patients 3 years of age and older with...
New Drug Approvals (FDA) · More like this

See also: Chronic Myelogenous Leukemia, Hepatitis B, Hepatitis C, Melanoma, Metastatic, Renal Cell Carcinoma, Thrombocythemia

Having trouble finding what you want?


MedNotes
Advertisement

(web2)